Search for: "Label v Label" Results 5061 - 5080 of 13,304
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Sep 2015, 9:49 am
Federal district court issued a landmark ruling in House of Representatives v. [read post]
10 Sep 2015, 8:32 am
Incidentally, the 81,423-wordjudgment does not contain the W word ...There has just fallen onto the desk of this Kat the judgment of Mr Justice Arnold at first instance following the full trial in the long-running case of Mylan and Actavis v Warner-Lambert. [read post]
9 Sep 2015, 2:21 pm by Cynthia Marcotte Stamer
Solutions Law Press, Inc. is happy to share information about this upcoming free health industry study group meeting on 9/15/2015 in Irving, Texas. [read post]
9 Sep 2015, 1:59 pm by Gina Reif Ilardi and Molly Masenga
Discussing this standard, the California Supreme Court, in Kwikset Corp. v. [read post]
8 Sep 2015, 3:42 pm by Lisa Larrimore Ouellette
., John Thomas (2003), Arti Rai (2003), Tim Holbrook (2003), Craig Nard (1995), and much of the briefing in Teva v. [read post]
6 Sep 2015, 4:30 am by Barry Sookman
It’s Hard to Measure https://t.co/phkXQiT7kE via @itifdc -> No expectation of privacy in subscriber information, R. v. [read post]
4 Sep 2015, 5:41 am by SHG
Lawprof Paul Gowder tried to hijack the post, reflecting his need to reread Matthews v. [read post]
3 Sep 2015, 3:06 pm by Lawrence B. Ebert
In re Anthony,414 F.2d 1383 (CCPA 1969) (FDA, not USPTO, is responsible for safety ofdrugs which are sought to be patented); In re Watson, 517 F.2d 465 (CCPA1975) (Congress has given responsibility to FDA, not USPTO, to determinein the first instance whether drugs are safe); Purdue Pharma L.P. v. [read post]
3 Sep 2015, 7:14 am by Joy Waltemath
Notably, the signed pages produced by the employee were labeled 2-0603 (06 representing the year 2006 and 03 representing March) and the remaining internal pages bore the label 2-0901 (09 for 2009 and 01 for January). [read post]
2 Sep 2015, 9:05 pm by Walter Olson
” [Ann Althouse] Citing First Amendment, federal court enjoins FDA from prohibiting truthful speech by drugmakers about off-label uses [WSJ, Alex Tabarrok (in recent years, federal government “has extracted billions of dollars in settlements from pharmaceutical firms for engaging in what appears to be constitutionally protected speech”), Beck and Sullivan, Drug & Device Law on Amarin v. [read post]